Business Standard

DOLO-650 makers distributed freebies worth Rs 1,000 cr to doctors: FMRAI

The petitioner, while seeking statutory backing to the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), said that corruption in pharma marketing practices is yet unregulated in India

drugs, pharma, prices, drug prices, medicines, health
Premium

BS Web Team New Delhi
The Central Board for Direct Taxes (CBDT) has accused the makers of the Dolo-650 tablet of spending Rs 1,000 crore to distribute freebies to doctors for prescribing the medicine.

In the Federation of Medical & Sales Representatives Association of India (FMRAI) vs Union of India case, advocate Sanjay Parikh, representing FMRAI, said that DOLO had invested the amount in 'freebies' to have it prescribed, according to Bar and Bench (B&B).

Public interest litigation (PIL) was filed in the court through advocate Aparna Bhat that sought statutory backing from the Uniform Code of Pharmaceutical Marketing Practices (UCPMP). It stated that the

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 18 2022 | 5:03 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com